Ortho Micronor is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is Norethindrone.
| Product ID | 50458-194_86d3d5c2-638b-11ea-aebd-792bfc2ca371 |
| NDC | 50458-194 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ortho Micronor |
| Generic Name | Norethindrone |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1973-01-02 |
| Marketing End Date | 2025-05-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA016954 |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | NORETHINDRONE |
| Active Ingredient Strength | 0 mg/1 |
| Pharm Classes | Progesterone Congeners [CS],Progestin [EPC] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2018-02-01 |
| Marketing End Date | 2021-04-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA016954 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-03-05 |
| Marketing End Date | 2025-05-31 |
| Marketing Category | NDA |
| Application Number | NDA016954 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1973-01-02 |
| Marketing End Date | 2019-06-30 |
| Marketing Category | NDA |
| Application Number | NDA016954 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1973-01-02 |
| Marketing End Date | 2025-05-31 |
| Marketing Category | NDA |
| Application Number | NDA016954 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-02-01 |
| Marketing End Date | 2021-04-30 |
| Marketing Category | NDA |
| Application Number | NDA016954 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1973-01-02 |
| Marketing End Date | 2020-05-31 |
| Marketing Category | NDA |
| Application Number | NDA016954 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-10-10 |
| Marketing End Date | 2020-05-31 |
| Ingredient | Strength |
|---|---|
| NORETHINDRONE | .35 mg/1 |
| SPL SET ID: | cc1fd49c-ba64-445e-8d03-f771a7439503 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50458-194 | Ortho Micronor | NORETHINDRONE |
| 51862-102 | Camila | Norethindrone |
| 51862-884 | CAMILA | NORETHINDRONE |
| 16714-440 | DEBLITANE | Norethindrone |
| 0555-0344 | Errin | Norethindrone |
| 51862-100 | Errin | Norethindrone |
| 51862-886 | ERRIN | NORETHINDRONE |
| 57297-877 | Jencycla | norethindrone |
| 52544-892 | Jolivette | NORETHINDRONE |
| 50102-300 | Lyleq | NORETHINDRONE |
| 53002-1793 | Lyleq | NORETHINDRONE |
| 50102-100 | LYZA | norethindrone |
| 53002-1687 | LYZA | norethindrone |
| 52544-629 | Nora BE | Norethindrone |
| 0378-7272 | Norethindrone | Norethindrone |
| 0378-7292 | NORETHINDRONE | norethindrone |
| 50090-2150 | Norethindrone | Norethindrone |
| 50090-6161 | NORETHINDRONE | NORETHINDRONE |
| 57297-876 | NORETHINDRONE | NORETHINDRONE |
| 63187-748 | Norethindrone | Norethindrone |
| 42291-650 | Norethindrone Acetate | Norethindrone |
| 50268-602 | Norethindrone Acetate | Norethindrone |
| 50090-3235 | Norlyda | norethindrone |
| 51660-127 | NORLYROC | norethindrone |
| 16714-441 | SHAROBEL | Norethindrone |
| 50102-200 | Tulana | NORETHINDRONE |
| 53002-2687 | Tulana | NORETHINDRONE |